癌症症状管理中的AI生成内容:聊天GPT和NCCN之间的比较分析
David Lazris1, Yael Schenker2, Teresa Hagan Thomas3
1Department of Medicine, (D.L, Y.C), University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
Journal of pain and symptom management
|June 28, 2024
概括
像ChatGPT这样的人工智能工具提供了可访问的癌症症状建议,但他们的建议与国家综合癌症网络 (NCCN) 的指导方针不同,这引发了对患者护理的担忧.
科学领域:
- 在瘤学瘤学.
- 医疗信息学 医疗信息学
- 医疗保健中的人工智能
背景情况:
- 来自像ChatGPT这样的AI工具的在线健康信息是常见的.
- 人工智能产生的内容与专业治疗指南的研究有限.
- 这项研究将ChatGPT的癌症症状建议与NCCN指南进行比较.
研究的目的:
- 将人工智能产生的症状管理建议与既定的临床指南进行比较.
- 评估ChatGPT和NCCN对癌症患者的建议之间的一致性.
- 评估人工智能生成的信息与基于指南的信息的可读性和简洁性.
主要方法:
- 提取了九种与癌症相关的症状的NCCN治疗建议.
- 查询了ChatGPT-3.5以获得类似症状管理建议.
- 对药物,咨询和非药物战略进行了比较内容分析.
- 分析了词数和弗莱什-金凯德等级水平 (FKGL) 以提高可读性.
主要成果:
- NCCN和ChatGPT之间的平均一致率为37.3%.
- NCCN提供了更具体的药物建议;ChatGPT建议用于便秘/腹的未列出的药物.
- 聊天GPT的内容比NCCN的指导方针要简洁和易读 (FKGL较低).
结论:
- 聊天GPT和NCCN指南之间的差异使得人工智能驱动的患者建议需要谨慎.
- 人工智能工具提供了可访问的信息,但需要根据基于证据的标准进行验证.
- 未来的研究应该探索将人工智能与最佳癌症患者支持指南相结合.
相关概念视频
Cancer Survival Analysis
342
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
342
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Mouse Models of Cancer Study
5.5K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
5.5K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K


